MedPath

Anxiety Among Children: Adaptation and Effectiveness of the Program Super Skills for Life in School Settings

Not Applicable
Completed
Conditions
Childhood Anxiety
Low Self-Esteem
Quality of Life (QOL)
Behavioral Problems
Childhood Depression
Social Skills
Emotional Problems
Registration Number
NCT07162402
Lead Sponsor
Fatima Jinnah Women University
Brief Summary

Super Skills for Life (SSL) is a transdiagnostic prevention program designed for children with anxiety and depressive symptoms based on cognitive-behavioral therapy. This study is a Cluster Randomization Trial(cRCT) to determine the of the effectiveness of the SSL program to reduce anxiety and depressive symptoms along with improving self-esteem, social skills and overall quality of life in a sample of 126, 5th grade children recruited from 6 schools from Pakistan.

Schools were the unit of randomization and were randomly assigned to one of two experimental conditions; intervention group (SSL) and waiting list control (WLC) group. Assessments were conducted before and after the 8 sessions of intervention and follow-up assessment after 6 months.

Detailed Description

Super Skills for Life (SSL) is a transdiagnostic prevention program designed for children with anxiety and depressive symptoms based on cognitive-behavioral therapy. This study is a Cluster Randomization Trial(cRCT) to determine the of the effectiveness of the SSL program to reduce anxiety and depressive symptoms along with improving self-esteem, social skills and overall quality of life in a sample of 126, 5th grade children recruited from 6 schools from Pakistan.

Schools were the unit of randomization and were randomly assigned to one of two experimental conditions; intervention group (SSL) and waiting list control (WLC) group. Assessments were conducted before and after the 8 sessions of intervention and follow-up assessment after 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • Inclusion Criteria of the study was a selection of children of Grade 5th presented with anxiety symptoms according to their scores equal to or greater than 25 on a total scale score of The Screen for Child Anxiety Related Emotional Disorders (SCARED) with age 9 and 13 years, who can speak and understand Urdu easily.
Exclusion Criteria
  • Children who have any serious physical/medical diseases, diagnosed mental health issues, developmental delays, or learning difficulties, and are under any psychological treatment were excluded. Furthermore, children who had undergone any surgery or experienced serious traumatic events in the past 6 months and who did not get permission from their parents with written informed consent from parents/ not willing to were also excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
The Screen for Child Anxiety Related Emotional Disorders (SCARED)Immediately after Intervention and Followup after 6 months

Psychometric tool for Anxiety Measurement

The Center for Epidemiological Studies Depression Scale for Children (CES-DC)Immediately post intervention and after 6 months

Psychometric Tool for the measurement of Depression

Secondary Outcome Measures
NameTimeMethod
The Strength and Difficulties Questionnaire (SDQ)Immediately post intervention and after 6 months

Tool for the measurement of overall emotional and behavioural problems

Rosenberg Self-Esteem Scale (RSES)Immediately after intervention and after 6 months

Scale for assessing Self-Esteem

Social Skills Questionnaire (SSQ)immediately after intervention and after 6 months

tool for assessing Social Skills

Pediatric Quality of Life Inventory (PedsQL)immediately after intervention and after 6 months

tool for assessing Pediatric Quality of Life

Trial Locations

Locations (1)

Fatima Jinnah Women University

🇵🇰

Rawalpindi, Punjab Province, Pakistan

Fatima Jinnah Women University
🇵🇰Rawalpindi, Punjab Province, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.